Statistical approaches for component-wise censored composite endpoints
Clinical Trials · 2024
DOI: 10.1177/17407745241265628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials, 2024. Verfasst von Anne Eaton. Beteiligte Einrichtung: Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Endpoint Determination, HIV Infections, Randomized Controlled Trials as Topic. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, national cancer institute.
Abstract (Originalsprache)
Composite endpoints defined as the time to the earliest of two or more events are often used as primary endpoints in clinical trials. Component-wise censoring arises when different components of the composite endpoint are censored differently. We focus on a composite of death and a non-fatal event where death time is right censored and the non-fatal event time is interval censored because the event can only be detected during study visits. Such data are most often analysed using methods for right censored data, treating the time the non-fatal event was first detected as the time it occurred. This can lead to bias, particularly when the time between assessments is long. We describe several approaches for estimating the event-free survival curve and the effect of treatment on event-free survival via the hazard ratio that are specifically designed to handle component-wise censoring. We apply the methods to a randomized study of breastfeeding versus formula feeding for infants of mothers infected with human immunodeficiency virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Anne Eaton
Förderung
- NCI NIH HHS
- national cancer institute
Zitieren
APA
Eaton, A. (2024). Statistical approaches for component-wise censored composite endpoints. Clinical Trials. https://doi.org/10.1177/17407745241265628
Vancouver
Eaton A. Statistical approaches for component-wise censored composite endpoints. Clinical Trials. 2024. doi:10.1177/17407745241265628
BibTeX
@article{Eaton2024,
author = {Eaton, Anne},
title = {Statistical approaches for component-wise censored composite endpoints},
journal = {Clinical Trials},
year = {2024},
doi = {10.1177/17407745241265628}
}
EUVIMED